In recent years, different combinations of #systemictherapy for metastatic hormone-sensitive #prostatecancer (mHSPC) with doublet and even triple therapy have been introduced with different results in
Review #EAUGuidelines on Upper Urinary Tract Urothelial Cell Carcinoma (#UTUC) with this #EAUUrologyCheatSheets! See the newest recommendations for both metastatic and non-metastatic disease management.
Bladder cancer is the 7th most commonly diagnosed cancer in males, and ~75% of patients have non-muscle-invasive bladder carcinomas (#NMIBC). Review the #EAUGuidelines on staging
#BladderCancer is the 7th most commonly diagnosed #cancer in males. For ~35% of patients, bladder cancer is muscle-invasive or #metastatic at presentation. Review the #EAUGuidelines on #MIBC in just one page with this #EAUUrologyCheatSheets
Androgen deprivation therapy is the most widely used systemic treatment for prostate cancer. It is the first line of treatment against advanced prostate cancer and is